US2021000736A1PendingUtilityA1

Lipofilling with ex-vivo expanded adipose tissue-derived stem cells for cosmetic breast filling or for facial filling and/or rejuvenation

Assignee: STEMFORM APSPriority: Jun 26, 2013Filed: Sep 25, 2020Published: Jan 7, 2021
Est. expiryJun 26, 2033(~6.9 yrs left)· nominal 20-yr term from priority
A61Q 19/08A61Q 19/00A61L 27/3804A61L 27/3604A61K 8/981C12N 5/0667A61L 2430/34A61L 2430/04A61L 2400/06A61K 2800/91
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a composition comprising ex-vivo expanded adipose tissue derived stem cell (ASC) or ex-vivo expanded adipose tissue-derived stem cells (ASC) mixed with harvested fat tissue at a ratio of 5,0×10 4 −2,0×10 8 ASCs/mL fat; for example 1,0×10 5 −2,0×10 7 and the use of ex-vivo expanded adipose tissue-derived stem cells or ex-vivo expanded adipose tissue-derived stem cell enriched fat grafts as an agent for cosmetic breast filling/augmentation or for facial filling/rejuvenation.

Claims

exact text as granted — not AI-modified
1 . A composition comprising ex-vivo expanded adipose tissue-derived stem cell (ASC) enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells (ASC) mixed with harvested fat tissue at a ratio of 5,0×10 4 −2,0×10 8  ASCs/mL fat. 
     
     
         2 . Use of ex-vivo expanded adipose tissue-derived stem cell enriched fat grafts as a breast filling agent. 
     
     
         3 . Use of ex-vivo expanded adipose tissue-derived stem cell enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells as a facial filling agent. 
     
     
         4 . Use of ex-vivo expanded adipose tissue-derived stem cell enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells for cosmetic breast filling. 
     
     
         5 . Use of ex-vivo expanded adipose tissue-derived stem cell enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells for cosmetic facial filling. 
     
     
         6 . Cosmetic method of breast filling wherein adipose tissue-derived stem cell (ASC) enriched fat grafts is mixed with harvested fat tissue at a ratio of 5,0×10 4 −2,0×10 8  ASCs/mL fat, and wherein the fat is injected as aliquots or as strings with a long needle horizontally (parallel to the body) by inserting the needle from several points around the areola margin and at several points at the inframammary fold in variable directions and planes to achieve an even and natural appearing distribution of the graft. 
     
     
         7 . Cosmetic method of facial filling wherein expanded adipose tissue-derived stem cell (ASC) enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells (ASC) are mixed with harvested fat tissue at a ratio of 5,0×10 4 −2,0×10 8  ASCs/mL fat or solved in PBS in order to evenly distribute the cells, and wherein the fat grafts are injected as aliquots or as strings with a long needle horizontally (parallel to the surface) to avoid damaging structures outside the target area and the needle is inserted from several points and in variable directions and planes to achieve an even and natural appearing distribution of the graft. 
     
     
         8 . Cosmetic method of facial filling wherein expanded adipose tissue-derived stem cell (ASC) enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells (ASC) are mixed with harvested fat tissue at a ratio of 5,0×10 4 −2,0×10 8  ASCs/mL fat or solved in PBS in order to evenly distribute the cells, and wherein the solved ASCs are injected in the dermis with a thin sharp needle and evenly distributed in the target area and the incision and injection sites are sutured and postoperative compression garments are applied to the donor sites and in some cases also to the recipient sites. 
     
     
         9 . Cosmetic method of introducing an agent to the skin wherein the agent comprises ex-vivo expanded adipose tissue-derived stem cell enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells. 
     
     
         10 . Cosmetic method of introducing an agent to the skin wherein the agent comprises ex-vivo expanded adipose tissue-derived stem cell (ASC) enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells (ASC) mixed with harvested fat tissue at a ratio of 5,0×10 4 −2,0×10 8  ASCs/mL fat.

Join the waitlist — get patent alerts

Track US2021000736A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.